Onderneming SciClone Pharmaceuticals (Holdings) Limited
Aandelen
6600
KYG4271B1023
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18 HKD | +0,11% | 0,00% | +29,31% |
01/04 | SciClone Pharmaceuticals boekt 31% meer winst in 2023 | MT |
28/03 | Sciclone Pharmaceuticals (Holdings) Limited kondigt wijzigingen in de leiding aan | CI |
Vakgebied
Aantal werknemers: 860
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 3 035 | 100,0 % | 3 198 | 100,0 % | +5,35% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
97,0
%
| 2 967 | 97,8 % | 3 103 | 97,0 % | +4,58% |
Others
3,0
%
| 68 | 2,2 % | 94 | 3,0 % | +38,74% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hong Zhao
CEO | Chief Executive Officer | 60 | 01-06-20 |
Rong Rong Pan
DFI | Director of Finance/CFO | 46 | - |
Mao Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 13-06-22 |
Lian Zong Wu
PRN | Corporate Officer/Principal | 50 | - |
Min Jia
PRN | Corporate Officer/Principal | 53 | - |
Yan Song Chang
PRN | Corporate Officer/Principal | 56 | - |
Ming Xiang Wu
PRN | Corporate Officer/Principal | 58 | - |
Chih Wen Shao
PRN | Corporate Officer/Principal | 61 | - |
Lingyu Zhu
PRN | Corporate Officer/Principal | 54 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Vasella
BRD | Director/Board Member | 70 | 01-06-20 |
Hong Zhao
CEO | Chief Executive Officer | 60 | 01-06-20 |
Zhen Fu Li
CHM | Chairman | 59 | 01-06-20 |
Guo En Liu
BRD | Director/Board Member | 67 | - |
Wendy Hayes
BRD | Director/Board Member | 54 | 01-03-21 |
Yushao Gu
BRD | Director/Board Member | 55 | - |
Rong Rong Pan
DFI | Director of Finance/CFO | 46 | - |
Ping Chen
BRD | Director/Board Member | 66 | - |
Hai Xia Wang
BRD | Director/Board Member | 50 | 16-06-21 |
Director/Board Member | 42 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 627 646 692 | 339 329 011 ( 54,06 %) | 0 | 54,06 % |
Bedrijfsgegevens
SciClone Pharmaceuticals (Holdings) Ltd.
22/F, Central Plaza 381 Middle Huaihai Road
200020, Shanghai
+
http://www.sciclone.comSector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,31% | 1,4 mld. | |
-4,66% | 87,53 mld. | |
+1,32% | 40,42 mld. | |
-19,27% | 29,48 mld. | |
+57,86% | 25,43 mld. | |
-17,69% | 11,49 mld. | |
-43,00% | 11,3 mld. | |
-9,14% | 11,1 mld. | |
+5,24% | 8,75 mld. | |
-8,42% | 7,99 mld. |
- Beurs
- Aandelen
- Koers 6600
- Onderneming SciClone Pharmaceuticals (Holdings) Limited